OA06.04 Phase II Study of Pembrolizumab and Itacitinib for Patients with Metastatic NSCLC Expressing PD-L1: Long-Term Follow up.

Details

Language :

English

ISSN :

15560864

Volume :

19

Issue :

10

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

180334880

Full Text :

https://doi.org/10.1016/j.jtho.2024.09.042